ANDA 86944, held by Ani Pharms. Dipyridamole.
As of Nov 16, 2026, ANDA 86944 (Dipyridamole), held by Ani Pharms, was first approved by FDA on Apr 16, 1991, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 16, 1991 | Original application | Approved | None posted |
| Dipyridamole50MG · tablet;oral | Dipyridamole | Discontinued |
| Dipyridamole25MG · tablet;oral | Dipyridamole | Discontinued |
| Dipyridamole75MG · tablet;oral | Dipyridamole | Discontinued |
| Jan 12, 2024 | Supplement 41Manufacturing | Approved | None posted |
| May 9, 2001 | Supplement 36Manufacturing | Approved | None posted |
| Jan 12, 1995 | Supplement 35Manufacturing | Approved | None posted |
| Mar 12, 1992 | Supplement 34Labeling | Approved | None posted |
| Apr 16, 1991 | Supplement 31Labeling | Approved | None posted |
| Apr 16, 1991 | Original application | Approved | None posted |
| Nov 20, 1989 | Supplement 32Labeling | Approved | None posted |
| Apr 26, 1989 | Supplement 30Bioequivalence | Approved | None posted |
| Nov 20, 1986 | Supplement 29Manufacturing | Approved | None posted |
| Jul 3, 1986 | Supplement 28Manufacturing | Approved | None posted |
| May 27, 1986 | Supplement 27Manufacturing | Approved | None posted |
| Apr 30, 1985 | Supplement 26Manufacturing | Approved | None posted |
| Apr 30, 1985 | Supplement 20Manufacturing | Approved | None posted |
| Aug 21, 1984 | Supplement 24Manufacturing | Approved | None posted |
| Dec 13, 1983 | Supplement 21Manufacturing | Approved | None posted |
| Jul 20, 1982 | Supplement 19Manufacturing | Approved | None posted |
| Jul 20, 1982 | Supplement 18Manufacturing | Approved | None posted |
| Jul 20, 1982 | Supplement 17Manufacturing | Approved | None posted |
| Mar 10, 1982 | Supplement 15Manufacturing | Approved | None posted |
| Mar 10, 1982 | Supplement 14Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters